Results 191 to 200 of about 81,676 (316)

A Shift from Standard Median Sternotomy to Robotic-Assisted Thoracic Surgery for Resection of Anterior Mediastinal Tumors. [PDF]

open access: yesJ Clin Med
Peer M   +11 more
europepmc   +1 more source

High expression of miR5700 in atypical type A thymoma and its role in promoting tumour progression

open access: yesClinical and Translational Discovery, Volume 6, Issue 1, February 2026.
The first discovery of miR5700 in tumour progression: 1. Atypical type A thymoma was the most invasive and metastatic subtype of thymic epithelial tumour, and difficult to diagnose in pathology owing to the scarcity of specific biomarkers and well‐defined molecular targets. 2. miR‐5700 was markedly overexpressed in atypical type A thymoma. 3.
Li Zhao   +4 more
wiley   +1 more source

Long-Term Outcomes of Patients With Mediastinal Radiation–Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting [PDF]

open access: bronze, 2020
Aaron Dunn   +13 more
openalex   +1 more source

Process Systems Engineering in Precision Medicine: Opportunities in Autologous CAR‐T Therapy

open access: yesEngineering in Life Sciences, Volume 26, Issue 2, February 2026.
ABSTRACT Autologous chimeric antigen receptor (CAR)‐T therapies have given hope to many cancer patients whose other lines of treatment have failed. Unfortunately, limited manufacturing capability has resulted in many patients dying while on a waitlist.
B. Wayne Bequette
wiley   +1 more source

Enhancing mediastinal mass at MR: Castleman disease

open access: green, 1993
Ming Lin Hsieh   +3 more
openalex   +2 more sources

Short-term outcomes of single- versus multi-port video-assisted thoracic surgery in mediastinal diseases [PDF]

open access: bronze, 2017
Qiuyuan Li   +6 more
openalex   +1 more source

Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients

open access: yesInternational Journal of Cancer, Volume 158, Issue 3, Page 682-696, 1 February 2026.
What's new? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy